Sterile sponges used in surgery for wound cleaning, can be responsible for serious complications or even death when they are not easily detected and removed. However, sterile X-ray detectable sponges are affordable, easily detected, and suitable for operating room and surgical applications. They are made of USP Type VII gauze, which contains heat-bonded barium sulfate marker that incorporates a dual-colored element to permit vivid and accurate X-ray visibility.
Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2249
Increasing awareness regarding use of sterile X-ray detectable lap sponges to reduce medical errors is expected to drive growth of the sterile X-ray detectable lap sponges market. For instance, according to an article published in the International Journal of Surgery and Medicine 2017, forgotten or missed foreign bodies, such as cotton sponges, gauze or instruments, after any surgical procedures may result into serious complications such as secondary infections, and tissue damage.
Product recalls due to failure in meeting sterile conditions is expected to hamper growth of the sterile X-ray detectable lap sponges market. For instance, in March 2016, the U.S Food and Drug Administration (USFDA) recalled Kerlix X-Ray Detectable Laparotomy Sponges, Tray Pack, 16″ x 17″ of Covidien LLC, due to failures in sterility of the product at package seal, which may result in a potentially increased risk of infection.
Key players operating in sterile X-ray detectable lap sponges market include, Medline Industries, Inc., Medtronic, Mölnlycke Health Care AB., PAUL HARTMANN AG, Baxter., 3M, BSN medical., Smith & Nephew, Winner Medical Group Inc., and Johnson & Johnson Services, Inc.